Interrupted blood flow in the brain due to ischemic injuries such as ischemic stroke or
traumatic brain injury results in irreversible brain damage, leading to cognitive impairment …

Background Following an ischemic injury to the brain, the induction of angiogenesis is
critical to neurological recovery. The angiogenic benefits of mesenchymal stem cells (MSCs) …

Stroke is the leading cause of physical disability among adults. Stem cells such as
mesenchymal stem cells (MSCs) secrete a variety of bioactive substances, including trophic …

A stroke is a focal cerebral insult that frequently causes severe neurological deficit and
mortality. Recent studies have demonstrated that multipotent mesenchymal stromal cells …

Obtained from the right cell-type, mesenchymal stromal cell (MSC)-derived small
extracellular vesicles (sEVs) promote stroke recovery. Within this process, microvascular …

Mesenchymal stem cells (MSCs) exert their therapeutic capability through a variety of
bioactive substances, including trophic factors, microRNAs, and extracellular vesicles (EVs) …

Mesenchymal stem/stromal cells (MSCs) display a variety of therapeutically relevant effects,
such as the induction of angiogenesis, particularly under hypoxic conditions. It is generally …

Ischemic stroke is a debilitating disease and one of the leading causes of long-term
disability. During the early phase after ischemic stroke, the blood-brain barrier (BBB) exhibits …

Mesenchymal stem cell (MSC)‐derived extracellular vesicles (EVs) have emerged as
potential therapeutic agents for numerous applications. EVs offer potential advantages over …

Aim: Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) have been
reported to hold great potential as cell-free therapies due to their low immunogenicity and …